Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Markus Leweke

Showing results (11-20 of 120) with videos related to

Pageof 12
Sort By:
Addiction Biology|September 11, 2008
Acute and chronic cannabinoid treatment differentially affects recognition memory and social behavior in pubertal and adult ratsMiriam Schneider, Edgar Schömig, F Markus Leweke
Pharmacopsychiatry|January 24, 2024
Cannabidiol and its Potential Evidence-Based Psychiatric Benefits - A Critical ReviewInga Dammann, Cathrin Rohleder, F Markus Leweke
Expert Opinion on Pharmacotherapy|April 14, 2015
Drug repurposing and emerging adjunctive treatments for schizophreniaJan Malte Bumb, Frank Enning, F Markus Leweke
CNS Drugs|November 4, 2004
Cannabis-associated psychosis: current status of researchF Markus Leweke, Christoph W Gerth, Joachim Klosterkötter
Current Opinion in Psychiatry|February 20, 2020
Cannabidiol as a treatment option for schizophrenia: recent evidence and current studiesJulie Schoevers, Judith E Leweke, F Markus Leweke
Future Medicinal Chemistry|October 15, 2016
What is the promise of nicotinergic compounds in schizophrenia treatment?Juliane K Mueller, Cathrin Rohleder, F Markus Leweke
Handbook of Experimental Pharmacology|November 7, 2012
Medical needs in the treatment of psychotic disordersF Markus Leweke, Thorsten M Odorfer, J Malte Bumb
BMC Bioinformatics|October 16, 2009
Clinical bioinformatics for complex disorders: a schizophrenia case studyEmanuel Schwarz, F Markus Leweke, Sabine Bahn, et al.
Frontiers in Psychiatry|March 20, 2023
Cannabidiol enhances cerebral glucose utilization and ameliorates psychopathology and cognition: A case report in a clinically high-risk mental stateDagmar Koethe, Cathrin Rohleder, Lutz Kracht, et al.
Biological Psychiatry|February 8, 2016
Therapeutic Potential of Cannabinoids in PsychosisF Markus Leweke, Juliane K Mueller, Bettina Lange, et al.
Pageof 12

Showing results (11-20 of 120) with videos related to

Sort By:
Pageof 12
Addiction Biology|September 11, 2008
Acute and chronic cannabinoid treatment differentially affects recognition memory and social behavior in pubertal and adult ratsMiriam Schneider, Edgar Schömig, F Markus Leweke
Pharmacopsychiatry|January 24, 2024
Cannabidiol and its Potential Evidence-Based Psychiatric Benefits - A Critical ReviewInga Dammann, Cathrin Rohleder, F Markus Leweke
Expert Opinion on Pharmacotherapy|April 14, 2015
Drug repurposing and emerging adjunctive treatments for schizophreniaJan Malte Bumb, Frank Enning, F Markus Leweke
CNS Drugs|November 4, 2004
Cannabis-associated psychosis: current status of researchF Markus Leweke, Christoph W Gerth, Joachim Klosterkötter
Current Opinion in Psychiatry|February 20, 2020
Cannabidiol as a treatment option for schizophrenia: recent evidence and current studiesJulie Schoevers, Judith E Leweke, F Markus Leweke
Future Medicinal Chemistry|October 15, 2016
What is the promise of nicotinergic compounds in schizophrenia treatment?Juliane K Mueller, Cathrin Rohleder, F Markus Leweke
Handbook of Experimental Pharmacology|November 7, 2012
Medical needs in the treatment of psychotic disordersF Markus Leweke, Thorsten M Odorfer, J Malte Bumb
BMC Bioinformatics|October 16, 2009
Clinical bioinformatics for complex disorders: a schizophrenia case studyEmanuel Schwarz, F Markus Leweke, Sabine Bahn, et al.
Frontiers in Psychiatry|March 20, 2023
Cannabidiol enhances cerebral glucose utilization and ameliorates psychopathology and cognition: A case report in a clinically high-risk mental stateDagmar Koethe, Cathrin Rohleder, Lutz Kracht, et al.
Biological Psychiatry|February 8, 2016
Therapeutic Potential of Cannabinoids in PsychosisF Markus Leweke, Juliane K Mueller, Bettina Lange, et al.
Pageof 12